260 related articles for article (PubMed ID: 27906829)
1. Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection.
Parkes MD; Halloran PF; Hidalgo LG
Transplantation; 2017 Apr; 101(4):e102-e111. PubMed ID: 27906829
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.
Parkes MD; Halloran PF; Hidalgo LG
Am J Transplant; 2018 Jan; 18(1):63-73. PubMed ID: 28654216
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
[TBL] [Abstract][Full Text] [Related]
4. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors.
Venner JM; Hidalgo LG; Famulski KS; Chang J; Halloran PF
Am J Transplant; 2015 May; 15(5):1336-48. PubMed ID: 25787894
[TBL] [Abstract][Full Text] [Related]
5. CD160: a unique activating NK cell receptor.
Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
[TBL] [Abstract][Full Text] [Related]
6. CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.
Pahl JHW; Koch J; Götz JJ; Arnold A; Reusch U; Gantke T; Rajkovic E; Treder M; Cerwenka A
Cancer Immunol Res; 2018 May; 6(5):517-527. PubMed ID: 29514797
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development.
Victor AR; Weigel C; Scoville SD; Chan WK; Chatman K; Nemer MM; Mao C; Young KA; Zhang J; Yu J; Freud AG; Oakes CC; Caligiuri MA
J Immunol; 2018 Jan; 200(2):565-572. PubMed ID: 29229679
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
[TBL] [Abstract][Full Text] [Related]
9. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.
Hidalgo LG; Sellares J; Sis B; Mengel M; Chang J; Halloran PF
Am J Transplant; 2012 May; 12(5):1180-91. PubMed ID: 22390872
[TBL] [Abstract][Full Text] [Related]
10. Restricted processing of CD16a/Fc γ receptor IIIa
Patel KR; Roberts JT; Subedi GP; Barb AW
J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
[TBL] [Abstract][Full Text] [Related]
11. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
[TBL] [Abstract][Full Text] [Related]
12. The molecular phenotypes of rejection in kidney transplant biopsies.
Halloran PF; Famulski K; Reeve J
Curr Opin Organ Transplant; 2015 Jun; 20(3):359-67. PubMed ID: 25944235
[TBL] [Abstract][Full Text] [Related]
13. Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection.
Kildey K; Francis RS; Hultin S; Harfield M; Giuliani K; Law BMP; Wang X; See EJ; John G; Ungerer J; Wilkinson R; Kassianos AJ; Healy H
Front Immunol; 2019; 10():1877. PubMed ID: 31440252
[No Abstract] [Full Text] [Related]
14. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells.
Snyder KM; Hullsiek R; Mishra HK; Mendez DC; Li Y; Rogich A; Kaufman DS; Wu J; Walcheck B
Front Immunol; 2018; 9():2873. PubMed ID: 30574146
[TBL] [Abstract][Full Text] [Related]
15. Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.
Gantke T; Weichel M; Herbrecht C; Reusch U; Ellwanger K; Fucek I; Eser M; Müller T; Griep R; Molkenthin V; Zhukovsky EA; Treder M
Protein Eng Des Sel; 2017 Sep; 30(9):673-684. PubMed ID: 28981915
[TBL] [Abstract][Full Text] [Related]
16. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria.
Giustiniani J; Alaoui SS; Marie-Cardine A; Bernard J; Olive D; Bos C; Razafindratsita A; Petropoulou A; de Latour RP; Le Bouteiller P; Bagot M; Socié G; Bensussan A
Curr Mol Med; 2012 Feb; 12(2):188-98. PubMed ID: 22172098
[TBL] [Abstract][Full Text] [Related]
17. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
[TBL] [Abstract][Full Text] [Related]
18. Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.
Jing Y; Ni Z; Wu J; Higgins L; Markowski TW; Kaufman DS; Walcheck B
PLoS One; 2015; 10(3):e0121788. PubMed ID: 25816339
[TBL] [Abstract][Full Text] [Related]
19. CD160 is essential for NK-mediated IFN-γ production.
Tu TC; Brown NK; Kim TJ; Wroblewska J; Yang X; Guo X; Lee SH; Kumar V; Lee KM; Fu YX
J Exp Med; 2015 Mar; 212(3):415-29. PubMed ID: 25711213
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts.
Miyairi S; Baldwin WM; Valujskikh A; Fairchild RL
Transplantation; 2021 Feb; 105(2):284-290. PubMed ID: 32384380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
